#AMGEN
Big Pharma company Amgen went to court to block Colorado from limiting the cost of what hardworking Coloradans pay for one of their medications, Enbrel. And we’re fighting back!
(1/3)
November 16, 2026 at 10:00 PM
Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl
https://vivere.me/hjqf-k
Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl
vivere.me
November 17, 2026 at 2:50 PM
Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl
https://vivere.me/hjpq-k
Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl
vivere.me
November 17, 2026 at 2:20 PM
Massaroni (Amgen): "Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare"
Massaroni (Amgen): "Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare"
ebx.sh
November 18, 2026 at 4:42 AM
Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl

Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl. Attivi e sempre più attenti alle scelte che riguardano la propria salute,...
Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl
Rischio cardiovascolare, campagna Amgen accende i riflettori sul colesterolo Ldl. Attivi e sempre più attenti alle scelte che riguardano la propria salute,...
lamilano.it
November 17, 2026 at 2:27 PM
Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl

Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl. Attivi e sempre più attenti alle scelte che riguardano la propria...
Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl
Rischio cardiovascolare, campagna Amgen-Censis accende i riflettori sul colesterolo Ldl. Attivi e sempre più attenti alle scelte che riguardano la propria...
lamilano.it
November 17, 2026 at 2:06 PM
Massaroni (Amgen): “Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare”

Massaroni (Amgen): “Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare”. Il colesterolo Ldl, cosiddetto 'cattivo', è...
Massaroni (Amgen): “Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare”
Massaroni (Amgen): “Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare”. Il colesterolo Ldl, cosiddetto 'cattivo', è...
lamilano.it
November 17, 2026 at 1:56 PM
Kicked off Thanksgiving at our annual Operation Gobble Gobble! 🦃

We distributed 100 turkeys and groceries to local families. Thank you to VFW Post 10218, SGV Water, Niagara Cares, UNAC/UHCP, Amgen, California American Water, Golden State Water, and our volunteers for making it possible!
November 18, 2026 at 10:43 PM
Massaroni (Amgen): "Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare"
https://vivere.me/hjpp-k
Massaroni (Amgen): "Con campagna Io non mi faccio placcare più consapevolezza sul rischio cardiovascolare"
vivere.me
November 17, 2026 at 2:20 PM
Plan?
Plan?
You want a Plan?
Ask Merck, Eli Lilly, Pfizer, AstraZeneca, Pfizer, Sanofi, Novo Nordisk, GSK, Amgen, Gilead et al.
What's that you say?
"they created the problem you dick".
November 16, 2026 at 8:29 PM
Yeah. Let the ongoing trials from Amgen and Lilly finish out and move on. But this might turn into Vitamin D as well 🙈
November 19, 2026 at 2:28 PM
AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE

Only Global Phase 3 Trial to Show Clinically Meaningful Improvements in Systemic Disease Activity and Patient-Reported Symptoms of Sjögren's Disease

www.amgen.com/newsroom/pre...

#Sjogrens #Sjögrens #GoodNews #Research
AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE| Amgen
www.amgen.com
November 12, 2026 at 3:41 AM
New House STOCK Act disclosure: David J. Taylor reported a sale of Amgen Inc. - Common Stock (AMGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-11-03. Filed: 2026-11-12....

https://www.narrowit.com/politics-trading/a39aec53cad9547d5ae7
#CongressTrading #StockAct #House #AMGN #HousePtr
David J. Taylor Sale Disclosure - Amgen Inc. - Common Stock (AMGN) [ST] | Narrowit.com
David J. Taylor filed a House STOCK Act disclosure reporting a sale of Amgen Inc. - Common Stock (AMGN) [ST]. Amount: $1,001 - $15,000. Transaction date: 2026-11-03. Filed: 2026-11-12.
www.narrowit.com
November 14, 2026 at 2:21 AM
Tento týden nabídne Wall Street několik významných událostí. Dividendáře zaujmou například Exxon Mobil, Chevron, #microsoft či Amgen , u nichž připadaj… https://zpravy.kurzy.cz/882042/
November 16, 2026 at 4:04 PM
We need more States doing this, but unless we reform federal patent law, drug companies will keep using it to block state efforts. That’s what happened with Colorado. State and Federal reforms work together. We need both.
www.statnews.com/pharmalot/20...
U.S. judge blocks Colorado's first-of-its-kind price cap on an Amgen drug
A federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by Amgen
www.statnews.com
November 18, 2026 at 6:47 PM
#$AMGN top trade: 423 Dec 11 puts, $605K.
#$AMGN options, latest session: $11.0M in premium, 66% calls ($7.3M vs $3.7M in puts).
A 66/34 lean to calls: a tilt, not a one-sided bet.

Full story at the link.
#optionsflow #stocks #optionstrading #stockmarket
Institutional Flow in Amgen (AMGN): 66% of the Options Money Is in Calls
Traders are piling into Amgen (AMGN) options, mostly in calls. See the largest unusual trade, the expiry and how the stock is setting up.
globaltradersacademy.com
November 18, 2026 at 8:07 PM
Chevron is the dead smack heart of the United States. Amgen’s a sleeper
November 13, 2026 at 1:57 AM
#$AMGN: Taking an Amgen drug alone does not put your records in its systems. The suit alleges data from patient support and copay programs was taken. No claim yet: openclassactions.com/lawsuits/dat...
Amgen Data Breach Lawsuit: Patient Health Data Stolen
A proposed class action followed Amgen's SEC filing saying patient health information was exfiltrated from cloud systems run by outside vendors.
openclassactions.com
November 15, 2026 at 8:27 PM
#$AMGN: Dark pool shares by session (share of volume): Nov 13 392,309 (18.5%).
On Nov 13 dark pool activity ran 0.5x normal; the 5-day trend is fading.

Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.

Full story at the link.
#darkpool #stocks #stockmarket
Amgen (AMGN) Week Ahead: Options Flow Leans to Calls, Pricing a 3.2% Move
Amgen (AMGN) week ahead: the options market's expected move, where the options money sits, last week's dark pools and the levels that matter (Nov 14).
globaltradersacademy.com
November 14, 2026 at 1:17 PM
The page treats "disclosed A, claimed broader than A" as 2 separate failures depending on direction: Amgen shows breadth without enablement, Juno shows breadth without possession, and it argues each specification might have survived the other's test. obviouslynot.ai/how-broadly-can-i-claim
November 18, 2026 at 11:35 PM
#$AMGN traded 0.7x its normal off-exchange volume on Nov 16, 5-day trend fading.
#$AMGN at $456.74, 0.4% below its 20-day average ($458.61).
Big-block activity is cooling: price is being set on the lit market.

Full story at the link.
#darkpool #stocks #stockmarket
Amgen (AMGN) Institutional Flow at 2:45 PM: 94% of the Options Money in Calls
Amgen (AMGN) at 2:45 PM ET: options money leaning to calls. The latest institutional flow, the biggest unusual bets and what would confirm or invalidate the move.
globaltradersacademy.com
November 17, 2026 at 8:03 PM
I've been watching $AMGN. Amgen reported Phase 3 Sjogren's win: CD40-CD40L blockade curbs germinal-centre B cell activation and autoantibody titres. Like refocusing a lens on pathogenic B cells. https://wsau.com/2026/11/11/amgens-experimental-sjogrens-drug-meets-late-stage-trial-goal/
November 17, 2026 at 2:05 PM